Search
for
Sort by
Research 211–240 of 1000+
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Cholecalciferol-grafted hollow mesoporous silica nanoparticles for targeted and sustained caffeine delivery in alopecia therapy
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Suppression of FOXO1 activity by SIRT1-mediated deacetylation weakening the intratumoral androgen autocrine function in glioblastoma
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Hair Changes due to Drugs
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Cancer-Related Alopecia Risk and Treatment
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- HAIR REGROWTH
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Management of congenital ichthyoses: European guidelines of care, part two
- A Novel 3D Printed Model of Infected Human Hair Follicles to Demonstrate Targeted Delivery of Nanoantibiotics
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Bioengineered microneedles and nanomedicine as therapeutic platform for tissue regeneration
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Journal for ReAttach Therapy and Developmental Diversities
- Redefining hormone resistance in prostate cancer
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- Ottawa, Ontario, Canada, February 13–16, 2013